Ipol vial 5ML
Ended Awarded Last action
- Contract number
- SPE2DR26F1W95
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $25,521
Award facts
- Contract value 100% obligated
- $25,521.30 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $25,521.30 firm fixed-price delivery order to AmerisourceBergen Drug Corp for 4570612270 IPOL Vial 5ML, an inactivated polio vaccine product. The award was issued on January 23, 2026, with an ultimate completion date of January 26, 2026, and represents a non-set-aside competitive procurement. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery order is issued under AmerisourceBergen's parent company Cencora, Inc.'s larger Indefinite Delivery Contract with DLA Troop Support Medical, valued at up to $999.99 million through December 31, 2031, which serves as the primary vehicle for supplying pharmaceutical products and medical supplies to support military healthcare programs globally.
AmerisourceBergen's role as a critical pharmaceutical distributor for federal medical procurement is well-established, with the company regularly fulfilling orders for vaccines, medications, and medical supplies across multiple therapeutic domains for the Defense Health Agency and other government healthcare systems. The IPOL vaccine delivery order reflects the company's ongoing support of military medical readiness and immunization programs. As a major healthcare solutions provider competing on a full and open basis, AmerisourceBergen demonstrates consistent capability to meet federal procurement requirements for essential medical commodities required by military treatment facilities and veterans' healthcare programs.
Quick answers
Who was awarded contract SPE2DR26F1W95?
SPE2DR26F1W95 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 23, 2026.
How much is contract SPE2DR26F1W95 worth?
The government has obligated $25,521 on SPE2DR26F1W95.
Is contract SPE2DR26F1W95 an order under another contract?
Yes. SPE2DR26F1W95 is a delivery order under SPE2DR25D2205, an indefinite delivery contract.
Was contract SPE2DR26F1W95 competed?
The extent of competition for SPE2DR26F1W95 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award